An estimated 3 out of 10 people using cannabis have a cannabis-related disorder, which suggests many are at risk for any adverse health effects.

Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio.

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester.